Can BETMAT Sustainable rFC Endotoxin Testing Improve Parenteral Drug Quality Control
(YorkPedia Editorial):- Dover, Delaware Jun 9, 2026 (Issuewire.com) – In modern biopharmaceutical manufacturing, maintaining stringent quality control (QC) for parenteral drug products is essential to ensuring product safety and regulatory compliance. Parenteral formulations such as intravenous injectables, vaccines, and monoclonal antibody preparations bypass natural biological barriers and enter directly into systemic circulation. As a result, even trace levels of bacterial endotoxins–lipopolysaccharides derived from Gram-negative bacteria–can induce strong pyrogenic responses and systemic inflammatory risks. For decades, the industry has relied on Limulus Amebocyte Lysate (LAL) assays derived from horseshoe crab blood. However, increasing…
Read More